The motion, however, does not impact the failure to warn claims that are largely the main focus of the litigation
[9] [10] Several factors may explain why some individuals experience fatigue whilst taking GLP-1 medications: Reduced caloric intake : The appetite-suppressing effects can lead to significantly lower food consumption, potentially resulting in inadequate energy intake, particularly if patients are not consuming balanced, nutrient-dense meals
Orforglipron is an oral, small-molecule GLP-1 receptor agonist that was administered once daily in tablet form in clinical trials
From supporting the normal function of nerve cells to supporting the formation of red blood cells and DNA synthesis
Long, M., Cai, L., Li, W., Zhang, L., Guo, S., Zhang, R., Zheng, Y., Liu, X., Wang, M., Zhou, X., Wang, H., Li, X., Li, L., Zhu, Z., Yang, G., & Zheng, H